Thus, it is highly possible that hepatic steatosis phenotype in HFD-fed RORαLKO mice may be resulted from both upregulated PPARγ activation and suppressed PPARα transcriptional activity in the absence of RORα. The gene discussed is PPARA; the disease is fatty liver disease.